Lv11
60 积分 2023-02-09 加入
Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis
14小时前
待确认
Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors
5天前
已完结
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis
2个月前
已完结
Comment on: “Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis”
2个月前
已完结
Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis
2个月前
已完结
Drug‐Induced Acute Pancreatitis: A Real‐World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database
2个月前
已完结
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for ramucirumab
3个月前
已完结
Immune-related adverse events in older adults: Data mining of the FDA Adverse Event Reporting System
4个月前
已完结
Signal mining of adverse reactions in the antiemetic drug ondansetron during pregnancy:A Real-World analysis of the FDA adverse Event Reporting System (FAERS)
4个月前
已完结
Predictors for the Development of Thromboembolic Events in Cancer Patients Treated with Bevacizumab, Ramucirumab, and Aflibercept: A Single-Institution Retrospective Analysis
5个月前
已完结
皖公网安备34019202002308
